BeStock  
Markets › Compare › VIR vs MLYS

VIR vs MLYS

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
VIR · Vir Biotechnology$11.78 ▲ 5.46%
MLYS · Mineralys Therapeutics$23.30 ▼ 1.40%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

5192134175217Oct 7, '25Apr 7, '26Oct 5, '26
  • VIR +108.1%
  • MLYS -38.1%

Head to head

MetricVIRMLYS
Price$11.78$23.30
Change today▲ 5.46%▼ 1.40%
Market cap$1.99B$2.06B
Return, 3 months+14.9%-23.5%
Return, year to date+95.4%-35.8%
Return, 1 year+110.7%-38.7%
P/E (TTM)-6.7-5.5
P/B2.03.7
P/E percentile vs own 5y––
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)–+13.0%
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price+78.3%+118.9%
Analyst buy share100%100%
RSI (14)6334
30-day volatility51.0%67.5%
Max drawdown, 1 year-25.6%-52.5%
Trend readStrong uptrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • MLYS is the largest of the group by market value.
  • VIR has returned the most over the past year.
  • VIR carries the lowest trailing P/E.
  • VIR has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top